{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:15:02Z","timestamp":1783131302877,"version":"3.54.6"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014851","name":"Bayer Animal Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210154","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T18:36:03Z","timestamp":1547145363000},"page":"e0210154","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-0334","authenticated-orcid":true,"given":"Joseph M.","family":"Blondeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantelle D.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10156-003-0279-X","article-title":"Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling","volume":"9","author":"DP Nicolau","year":"2003","journal-title":"Journal of Infection and Chemotherapy"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/47.2.129","article-title":"Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy","volume":"47","author":"R Dagan","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Disease Society of America\/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"JS Solomkin","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2298\/BAH0702237D","article-title":"The bacterial infections of respiratory tract of swine","volume":"23","author":"R Dosen","year":"2007","journal-title":"Biotechnology in Animal Husbandry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/104063879600800305","article-title":"A specific and sensitive PCR assay suitable for large-scale detection of toxigenic Pasteurella multocida in nasal and tonsillar swabs specimens of pigs","volume":"8","author":"EM Kamp","year":"1996","journal-title":"Journal of Veterinary Diagnostic Investigation"},{"key":"ref7","first-page":"131","article-title":"Porcine respiratory disease complex (PRDC): A review. I Etiology, epidemiology, clinical forms and pathoanatomical features","volume":"10","author":"I Bochev","year":"2007","journal-title":"Bulgarian Journal of Veterinary Medicine"},{"key":"ref8","first-page":"1331","article-title":"Haemophilus pleuropneumoniae infection in swine: a review","volume":"182","author":"TN Sebunya","year":"1983","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"ref9","unstructured":"Clinical and Laboratory Standards Institute (2013) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard\u2014fourth edition (VET01-A4)."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01968060","article-title":"Bacterial counts in cerebrospinal fluid of children with meningitis","volume":"9","author":"E Bingen","year":"1990","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3476(76)80003-0","article-title":"Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis","volume":"88","author":"W Feldman","year":"1976","journal-title":"Journal of Pediatrics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.76.6.505","article-title":"The specific polysaccharide content of pneumonic lungs","volume":"76","author":"AW Frisch","year":"1942","journal-title":"Journal of Experimental Medicine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/ajrccm\/142.5.1004","article-title":"Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients","volume":"142","author":"J Fagon","year":"1990","journal-title":"American Review of Respiratory Disease"},{"key":"ref14","unstructured":"McVey DS, Kuszak J. Bacterial isolates from the lungs of beef calves with bronchopneumonia associated with acute bovine respiratory disease.; 2010 December 4\u20135; Chicago, IL."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.43.7.1756","article-title":"Effect of fluoroquinolone concentration on selection of resistant mutants of <italic>Mycobacterium bovis<\/italic> BCG and <italic>Staphylococcus aureus<\/italic>","volume":"43","author":"Y Dong","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1120009X.2004.11782371","article-title":"The role of PK\/PD parameters to avoid selection and increase of resistance: mutant prevention concentration","volume":"16","author":"JM Blondeau","year":"2004","journal-title":"Journal of Chemotherapy"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-3164.2009.00856.x","article-title":"New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach","volume":"20","author":"JM Blondeau","year":"2009","journal-title":"Veterinary Dermatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","article-title":"Mutant prevention concentrations (MPC) of fluoroquinolones for clinical isolates of Streptococcus pneumo<italic>niae<\/italic>","volume":"45","author":"JM Blondeau","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/dks461","article-title":"Minimal inhibitory and mutant prevention concentrations for azithromycin, clarithromycin and erythromycin with clinical isolates of <italic>Streptococcus pneumoniae<\/italic>","volume":"68","author":"KL Metzler","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1179\/joc.2005.17.5.484","article-title":"Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric gram-negative urinary tract infection pathogens","volume":"17","author":"GT Hansen","year":"2005","journal-title":"Journal of Chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.icl.0000246872.73559.43","article-title":"Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae","volume":"33","author":"P Hedlin","year":"2007","journal-title":"Eye & Contact Lens"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jac\/dku389","article-title":"Mutant prevention concentration of tigecycline for clinical isolates of <italic>Streptococcus pneumoniae<\/italic> and <italic>Staphylococcus aureus<\/italic>","volume":"70","author":"CK Hesje","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/AAC.49.10.4166-4173.2005","article-title":"Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance","volume":"49","author":"HG Wetzstein","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vetmic.2012.05.006","article-title":"Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine isolates of <italic>Mannheimia haemolytica<\/italic>","volume":"160","author":"JM Blondeau","year":"2012","journal-title":"Veterinary Microbiology"},{"key":"ref25","first-page":"652","article-title":"Manual of Clinical Microbiology","author":"R Zbinden","year":"2015"},{"key":"ref26","first-page":"1","article-title":"PK-PD integration modeling and cutoff value of florfenicol against <italic>Streptococcus suis<\/italic> in pigs","volume":"9","author":"Z Lei","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Hesje C, Borsos S, Blondeau JM. Determination of the minimum inhibitory concentration and mutant prevention concentration (MPC) of tigecycline against clinical isolates of Streptococcus pneumoniae: impact of media on MPC results.; 2007 March 31-April 3; Munich, Germany.","DOI":"10.1016\/S0924-8579(07)71895-2"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e0177568","DOI":"10.1371\/journal.pone.0177568","article-title":"Pharmacokinetic\/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida","volume":"12","author":"L Dorey","year":"2017","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/JCM.33.9.2435-2444.1995","article-title":"Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark","volume":"33","author":"SA Salmon","year":"1995","journal-title":"J Clin Microbiol"},{"key":"ref30","first-page":"30","article-title":"Antimicrobial susceptibility of porcine Pasteurella multocida, Streptococcus suis, and Actinobacillus pleuropneumoniae from the United States and Canada, 2001 to 2010","volume":"21","author":"E Portis","year":"2013","journal-title":"Journal of Swine Health and Production"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetmic.2004.11.015","article-title":"Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease","volume":"106","author":"SJ Shin","year":"2005","journal-title":"Vet Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ja.2009.111","article-title":"Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant <italic>Acinetobacter baumannii<\/italic>","volume":"63","author":"JC Cui","year":"2010","journal-title":"Journal of Antibiotics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jac\/dkg255","article-title":"Stretching the mutant prevention concentration (MPC) beyond its limits","volume":"51","author":"H Smith","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/AAC.47.5.1604-1613.2003","article-title":"<italic>In vitro<\/italic> pharmacodynamic evaluation of the mutant selection window hypothesis: four fluoroquinolones against <italic>Staphylococcus aureus<\/italic>","volume":"47","author":"AA Firsov","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2014.06.013","article-title":"Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations","volume":"44","author":"AA Firsov","year":"2014","journal-title":"International Journal of Antimicrobial Agents"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkl387","article-title":"Testing the mutant selection window hypothesis with <italic>Staphylococcus aureus<\/italic> exposed to daptomycin and vancomycin in an in vitro dynamic model","volume":"58","author":"AA Firsov","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"K Drlica","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkg401","article-title":"Emergence of resistant <italic>Streptococcus pneumoniae<\/italic> in an <italic>in vitro<\/italic> dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing","volume":"52","author":"SH Zinner","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1128\/AAC.48.5.1699-1707.2004","article-title":"Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy","volume":"48","author":"D Croisier","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref40","first-page":"60","article-title":"Pharmacokinetics and lung tissue concentrations of tulathromycin, anew triamilide antibiotic, in cattle","volume":"5","author":"MA Nowakowski","year":"2004","journal-title":"Veterinary Therapeutics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1345\/aph.17299","article-title":"Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions","volume":"32","author":"RP Rapp","year":"1998","journal-title":"The Annals of Pharmacotherapy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00392","article-title":"Pharmacokinetic\/Pharmacodynamic modeling of tulathromycin against <italic>Pasteurella multocida<\/italic> in a porcine tissue cage model","volume":"8","author":"Q Zhou","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2885.2004.00586.x","article-title":"Pharmacokinetics and lung tissue concentrations of tulathromycin in swine","volume":"27","author":"HA Benchaoui","year":"2004","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"ref44","first-page":"34","article-title":"Antimicrobial concentrations in plasma and lung and their relationships to bacterial respiratory infections","volume":"63","author":"DGS Burch","year":"2010","journal-title":"The Pig Journal"},{"key":"ref45","first-page":"83","article-title":"Tulathromycin: an overview of a new triamilide antibiotic for livestock respiratory disease","volume":"6","author":"NA Evans","year":"2005","journal-title":"Veterinary Therapeutics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000237771","article-title":"Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations","volume":"24","author":"SM Singhvi","year":"1978","journal-title":"Chemotherapy"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/jac\/dkh443","article-title":"Impact of plasma protein binding on antimicrobial activity using time-killing curves","volume":"54","author":"MA Zeitlinger","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.01433-10","article-title":"Protein binding: do we ever learn?","volume":"55","author":"MA Zeitlinger","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"TH Dellit","year":"2007","journal-title":"Clinical Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T07:03:34Z","timestamp":1606028614000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210154"}},"subtitle":[],"editor":[{"given":"Andrew C.","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210154","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]}}}